Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical ...

Natera (NASDAQ:NTRA) has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its investigational multi-cancer early detection (MCED) blood test, marking a ...

From cutting heart valves without open-heart surgery to confronting Israel’s growing medical brain drain, Sheba cardiologist ...

Dubai brings the future of healthcare with Next Generation Medicine 2026 at Atlantis The Royal from November 7 to November 10 ...

A teenager has been given pioneering surgery to preserve his fertility after chemotherapy treatment. For the first time in ...

A specialized Saudi medical team has begun a complex separation surgery for 13-month-old Moroccan conjoined twins, Saja and Doha, at King Abdullah Specialist Children’s Hospital in Riyadh, following ...

John Fairbanks was diagnosed with AL-Amyloidsis, new treatment retrains cells to fight the disease.

NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.

"Rocky" franchise star Dolph Lundgren was considering ending his life after a yearslong battle with kidney cancer. A second opinion "saved" him.

On October 6, 2026 (US time), four startups in the United States announced major funding rounds in succession. These include Vinci ($250 million), which handles physical simulations for semiconductors ...

Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind erectile dysfunction gel Eroxon, reported positive results from an additional Eroxon Intense home user test ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted two Breakthrough Therapy Designations (BTDs) for telisotuzumab adizutecan (Temab-A; ABBV-400) in ...